Contagion Live articleshttps://www.contagionlive.com/newsContagion Live articles© 2026 MJH Life Sciences™ and Contagion Live. All rights reserved.Tue, 30 Jun 2026 15:23:05 +00005en-us14447https://www.contagionlive.com/newshttps://www.contagionlive.com/logo.webphttps://www.contagionlive.com/view/considering-diversified-treatment-strategies-to-combat-gonorrhea-resistancehttps://www.contagionlive.com/view/considering-diversified-treatment-strategies-to-combat-gonorrhea-resistance<![CDATA[Lao-Tzu Allan-Blitz, MD, MPH, discusses treatment strategies including resistance-guided therapy with molecular gyrA assays and the goal of potentially reintroducing ciprofloxacin as therapy for this infection. ]]>Tue, 30 Jun 2026 12:35:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/lenacapavir-hiv-prevention-purpose-trials-long-acting-prephttps://www.contagionlive.com/view/lenacapavir-hiv-prevention-purpose-trials-long-acting-prep<![CDATA[Jared Baeten, MD, PhD, discusses what the PURPOSE 1 and 2 trial data reveal about lenacapavir adherence, long-acting PrEP candidate selection, the treatment pipeline, and access barriers for twice-yearly injectable HIV prevention.]]>Mon, 29 Jun 2026 11:00:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/hackensack-meridian-health-joins-phase-3-trial-of-pfizer-s-investigational-c-difficile-vaccinehttps://www.contagionlive.com/view/hackensack-meridian-health-joins-phase-3-trial-of-pfizer-s-investigational-c-difficile-vaccine<![CDATA[Hackensack Meridian Health has joined Pfizer’s global phase 3 BEETHOVEN trial, aiming to enroll 1,000 participants to evaluate an investigational vaccine designed to prevent Clostridioides difficile infection in adults aged 65 years and older. Alex Lazo-Vasquez, MD, provides some insights around the trial.]]>Sun, 28 Jun 2026 11:06:40 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/european-commission-approves-glecaprevir-pibrentasvir-for-hepatitis-chttps://www.contagionlive.com/view/european-commission-approves-glecaprevir-pibrentasvir-for-hepatitis-c<![CDATA[The regulatory body approved AbbVie's glecaprevir/pibrentasvir (Maviret) for the treatment of acute hepatitis C virus infection in adults and children aged 3 years and older, making it the first and only therapy in the European Union approved for both acute and chronic HCV infection.]]>Sat, 27 Jun 2026 10:38:19 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/initiatives-to-strengthen-vaccine-policy-and-governance-in-ushttps://www.contagionlive.com/view/initiatives-to-strengthen-vaccine-policy-and-governance-in-us<![CDATA[Two new complementary initiatives from CIDRAP’s Vaccine Integrity Project and The Evidence Collective aim to evaluate and improve US vaccine policymaking, governance, and public trust amid ongoing changes to the nation's immunization infrastructure.]]>Fri, 26 Jun 2026 12:31:29 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/infectious-disease-regulatory-watch-june-highlightshttps://www.contagionlive.com/view/infectious-disease-regulatory-watch-june-highlights<![CDATA[There were a number of FDA approvals in recent weeks. Here is a listing of the approvals including the news reports and review of the phase 3 study data. ]]>Thu, 25 Jun 2026 12:30:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/hiv-equity-crisis-data-who-failinghttps://www.contagionlive.com/view/hiv-equity-crisis-data-who-failing<![CDATA[Oni Blackstock, MD, MHS, discusses why HIV prevention stalls despite breakthroughs: funding cuts, Medicaid gaps, and structural racism keep PrEP and care out of reach.]]>Wed, 24 Jun 2026 12:00:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/efflux-pump-inhibitor-restores-azithromycin-activity-against-multidrug-resistant-gram-negative-pathogenshttps://www.contagionlive.com/view/efflux-pump-inhibitor-restores-azithromycin-activity-against-multidrug-resistant-gram-negative-pathogens<![CDATA[Preclinical findings demonstrate that the novel efflux pump inhibitor TXA14007 significantly enhances azithromycin activity against multidrug-resistant Gram-negative bacteria, supporting a potential new oral treatment strategy for difficult-to-treat infections. Jesus Rosado-Lugo, PhD, offers insights on the study at ASM Microbe 2026.]]>Tue, 23 Jun 2026 12:40:17 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/mrna-based-influenza-vaccine-advances-against-hhs-resistancehttps://www.contagionlive.com/view/mrna-based-influenza-vaccine-advances-against-hhs-resistance<![CDATA[An FDA advisory committee voted unanimously to recommend mRNA-1010 for approval, after the Agency initially refused to review the application and HHS cancelled contracts supporting mRNA vaccine development.]]>Mon, 22 Jun 2026 13:41:26 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/vaccine-for-lassa-fever-succeeds-in-first-in-human-trialhttps://www.contagionlive.com/view/vaccine-for-lassa-fever-succeeds-in-first-in-human-trial<![CDATA[An investigational dual vaccine against Lassa fever and rabies demonstrates promise against priority target plaguing West Africa. ]]>Sun, 21 Jun 2026 10:44:13 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/review-of-cefepime-and-zidebactam-a-novel-antibiotic-approved-to-treat-complicated-urinary-tract-infectionshttps://www.contagionlive.com/view/review-of-cefepime-and-zidebactam-a-novel-antibiotic-approved-to-treat-complicated-urinary-tract-infections<![CDATA[In May 2026, the FDA approved a combination product of cefepime and zidebactam for the treatment of complicated urinary tract infections, including pyelonephritis, providing a new treatment option for multidrug-resistant gram-negative organisms. Here is a clinical overview of the newly approved antibiotic. ]]>Sat, 20 Jun 2026 10:16:35 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/fda-expands-merck-pneumococcal-vaccine-indication-to-include-at-risk-children-and-adolescentshttps://www.contagionlive.com/view/fda-expands-merck-pneumococcal-vaccine-indication-to-include-at-risk-children-and-adolescents<![CDATA[The FDA has approved an expanded indication for Merck's Capvaxive, allowing its use in children and adolescents aged 2 to 17 years with chronic medical conditions that increase their risk of pneumococcal disease following completion of a primary pneumococcal vaccination series.]]>Fri, 19 Jun 2026 13:12:58 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/fda-approves-first-generic-version-of-influenza-antiviral-baloxavirhttps://www.contagionlive.com/view/fda-approves-first-generic-version-of-influenza-antiviral-baloxavir<![CDATA[The FDA has approved the first generic version of baloxavir marboxil (Xofluza), expanding access to a single-dose oral treatment and postexposure prophylaxis option for influenza in patients 5 years or older.]]>Thu, 18 Jun 2026 17:14:36 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/fda-approves-tebipenem-pivoxil-as-first-oral-carbapenem-for-complicated-urinary-tract-infectionshttps://www.contagionlive.com/view/fda-approves-tebipenem-pivoxil-as-first-oral-carbapenem-for-complicated-urinary-tract-infections<![CDATA[The FDA has approved tebipenem pivoxil (Utebzi), the first oral carbapenem antibiotic in the US for adults with complicated urinary tract infections, including pyelonephritis, providing an effective oral alternative to IV therapy for many patients with resistant infections.]]>Thu, 18 Jun 2026 13:36:37 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/understanding-the-eradicate-trial-limitations-and-key-takeawayshttps://www.contagionlive.com/view/understanding-the-eradicate-trial-limitations-and-key-takeaways<![CDATA[Why ceftobiprole gains traction: infusion data and lab susceptibility reports help clinicians tackle stubborn Staph aureus bacteremia.]]>Thu, 18 Jun 2026 12:00:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/bepirovirsen-phase-3-results-offer-potential-cure-for-chronic-hepatitis-bhttps://www.contagionlive.com/view/bepirovirsen-phase-3-results-offer-potential-cure-for-chronic-hepatitis-b<![CDATA[One in five patients with chronic hepatitis B virus infection achieved functional cure in two phase 3 trials with the investigational agent.]]>Wed, 17 Jun 2026 08:42:50 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/hepatitis-month-in-review-mayhttps://www.contagionlive.com/view/hepatitis-month-in-review-may<![CDATA[The FDA's accelerated approval of bulvirtide for chronic hepatitis D headlined May's news. Learn more about the treatment's phase 3 clinical trial including its efficacy, safety profile, and clinician insights. May also included Viral Hepatitis Awareness Month and National Hepatitis Testing Day. Listen to a clinician talk about the significance of these awareness events. ]]>Tue, 16 Jun 2026 12:46:12 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/screwworm-the-flesh-eating-parasite-returning-to-the-spotlighthttps://www.contagionlive.com/view/screwworm-the-flesh-eating-parasite-returning-to-the-spotlight<![CDATA[After nearly 60 years of successful eradication in the United States, the New World screwworm (Cochliomyia hominivorax) has reemerged in North America, prompting renewed surveillance and containment efforts due to its ability to infest and destroy living tissue in animals and humans.]]>Mon, 15 Jun 2026 14:14:03 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/reductions-in-funding-personnel-will-leave-us-less-prepared-for-future-infectious-disease-outbreakshttps://www.contagionlive.com/view/reductions-in-funding-personnel-will-leave-us-less-prepared-for-future-infectious-disease-outbreaks<![CDATA[While Americans are being affected by Ebola and Hantavirus, the federal government has made concerted efforts to decrease biopreparedness programs, including reducing funding, and downsizing personnel who study and address high-consequence infectious diseases (HCID). Despite these efforts, the US has had protocols, infrastructure, and medical personnel in place to deal with these current situations. ]]>Sun, 14 Jun 2026 14:07:45 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/invivyd-vyd2311-phase-3-covid-19-trialhttps://www.contagionlive.com/view/invivyd-vyd2311-phase-3-covid-19-trial<![CDATA[Invivyd has dosed the first participants in LIBERTY, a phase 3 trial comparing VYD2311 to an mRNA COVID vaccine and coadministration, as the BLA-enabling DECLARATION trial completes enrollment.]]>Fri, 12 Jun 2026 12:00:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/hiv-testing-gap-what-clinicians-can-dohttps://www.contagionlive.com/view/hiv-testing-gap-what-clinicians-can-do<![CDATA[Joanne D. Stekler, MD, MPH, discusses why many Americans still miss HIV diagnosis—and how opt-out screening, rapid tests, self-tests, and same-day treatment close the gap.]]>Thu, 11 Jun 2026 15:30:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/when-fever-in-infants-is-invasive-bacterial-infectionhttps://www.contagionlive.com/view/when-fever-in-infants-is-invasive-bacterial-infection<![CDATA[Meta-analysis finds approximately 1% of well-appearing outpatient infants aged 60 to 90 days with fever have an invasive bacterial infection.]]>Thu, 11 Jun 2026 12:16:07 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/challenges-to-adopting-new-therapeutics-familiarity-diagnostics-and-real-world-use-in-persistent-bacteremiahttps://www.contagionlive.com/view/challenges-to-adopting-new-therapeutics-familiarity-diagnostics-and-real-world-use-in-persistent-bacteremia<![CDATA[ERADICATE trial data show ceftobiprole is well-tolerated with mostly mild GI effects and no emerging resistance versus daptomycin.]]>Thu, 11 Jun 2026 12:00:00 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/asm-initiative-aims-to-advance-phage-therapy-for-drug-resistant-infectionshttps://www.contagionlive.com/view/asm-initiative-aims-to-advance-phage-therapy-for-drug-resistant-infections<![CDATA[The American Society for Microbiology (ASM) is leveraging its new phage therapy coordination efforts to connect researchers and clinicians, standardize approaches, and explore how bacteriophages could complement antibiotics in the fight against antimicrobial resistance. Colleen Kraft, MD, offers some insights on the organization's plans to help grow this medical modality. ]]>Wed, 10 Jun 2026 13:02:23 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/from-pathogen-to-infectious-disease-diagnosis-cobas-mpx-e-adds-hev-to-nat-screeninghttps://www.contagionlive.com/view/from-pathogen-to-infectious-disease-diagnosis-cobas-mpx-e-adds-hev-to-nat-screening<![CDATA[A new multiplex blood-screening assay is streamlining transfusion safety by enabling simultaneous detection and discrimination of HIV, HBV, HCV, and hepatitis E in a single test, helping laboratories improve efficiency, reduce turnaround times, and strengthen blood supply resilience amid ongoing donation and staffing shortages. Nico Michel, PhD, of Roche Diagnostics, offers insights on this diagnostic.]]>Tue, 09 Jun 2026 17:22:05 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/once-weekly-hiv-pill-meets-phase-3-endpoints-advancing-potential-first-long-acting-oral-treatmenthttps://www.contagionlive.com/view/once-weekly-hiv-pill-meets-phase-3-endpoints-advancing-potential-first-long-acting-oral-treatment<![CDATA[A once-weekly oral HIV treatment combining islatravir and lenacapavir achieved its primary efficacy endpoint in 2 phase 3 trials, bringing the investigational regimen closer to becoming the first approved long-acting oral HIV therapy.]]>Mon, 08 Jun 2026 20:57:15 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/atb-finder-aims-to-transform-antibiotic-selection-by-replicating-real-world-infection-conditionshttps://www.contagionlive.com/view/atb-finder-aims-to-transform-antibiotic-selection-by-replicating-real-world-infection-conditions<![CDATA[A novel antimicrobial susceptibility testing platform, ATB Finder, is designed to improve treatment outcomes by evaluating antibiotics under conditions that closely mirror the infection site and microbial communities found in patients. George Tetz, MD, PhD, offers insights on this platform. ]]>Mon, 08 Jun 2026 15:14:45 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/what-the-fda-approval-of-buleviratide-hepcludex-means-for-chronic-hepatitis-d-treatmenthttps://www.contagionlive.com/view/what-the-fda-approval-of-buleviratide-hepcludex-means-for-chronic-hepatitis-d-treatment<![CDATA[The FDA's accelerated approval of this therapy provides the first approved treatment option for chronic hepatitis delta in the US. Anu Osinusi, MD, discusses how this targeted therapy is designed to slow disease progression and improve patient outcomes.]]>Mon, 08 Jun 2026 13:37:23 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/asm-microbe-conference-bringing-the-microbiology-community-togetherhttps://www.contagionlive.com/view/asm-microbe-conference-bringing-the-microbiology-community-together<![CDATA[American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration across disciplines and improving member engagement.]]>Sun, 07 Jun 2026 10:33:41 GMTContagion LiveusContagion Live Articleshttps://www.contagionlive.com/view/wastewater-surveillance-s-role-in-identifying-measles-outbreakshttps://www.contagionlive.com/view/wastewater-surveillance-s-role-in-identifying-measles-outbreaks<![CDATA[Kelly Oakeson, PhD, explains how Utah public health officials are leveraging a statewide wastewater surveillance system to monitor measles activity, identify emerging outbreaks, and supplement traditional case reporting.]]>Sat, 06 Jun 2026 10:39:40 GMTContagion LiveusContagion Live Articles